The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwMyeloma 2017 | Liquid biospy approaches for detecting MM and their optimization
Suzanne Trudel
• 18 Oct 2017
It has become apparent in recent years that low levels of ciculating tumor DNA can be detected in multiple myeloma (MM) patients through liquid biopsies. In this interview, Suzanne Trudel, MD, MSc, FRCPC, of the Princess Margaret Hospital, Toronto, Canada, gives an overview of how this approach may be refined in the coming years, so that it may replace the more invasive and painful bone marrow biopsy, in both clinical and research contexts.
